HIV medication adherence: The intersection of biomedical, behavioral, and social science research and clinical practice

Journal of Acquired Immune Deficiency Syndromes

Volumn 43, Issue SUPPL. 1, 2006, Pages

  Friedland, Gerald H ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AIDS; Antiretroviral therapy; Clinical practice; HIV; Medication adherence; Multidisciplinary collaboration

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CLINICAL PRACTICE; CLINICAL RESEARCH; CULTURAL FACTOR; HEALTH BEHAVIOR; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PATIENT CARE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; SOCIOLOGY; TREATMENT RESPONSE; VIRUS INHIBITION;

ANTI-HIV AGENTS; BEHAVIORAL SCIENCES; DRUG ADMINISTRATION SCHEDULE; HIV INFECTIONS; HUMANS; PATIENT COMPLIANCE; PHYSICIAN'S PRACTICE PATTERNS; RESEARCH;

EID: 33845361045     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000248333.44449.ea     Document Type: Article

References (30)

1. Centers for Disease Control. Twenty-five years of HIV/AIDS - United States, 1981-2006. MMWR Morb Mortal Wkly Rep. 2006;55:589-592.
2. Palella F, Delaney K, Morrman A, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;338:853-860.
3. Friedland G, Williams A. Attaining higher goals in HIV treatment: the central importance of adherence. AIDS. 1999;13(Supp1):S61-S72.
4. Wainberg M, Friedland G. Public health implications of antiretroviral therapy and HIV drug resistance. JAMA. 1998;279:1977-1983.
5. Haubrich R, Little S, Currier J, et al. The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. AIDS. 1999;13:1099-1107.
6. Garcia de Olalla P, Knobel H, Carmona A, et al. Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients. J Acquir Immune Defic Syndr. 2002;30:105-110.
7. Wood E, Hogg R, Yip B, et al. Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 X 10(9) cells/L. Ann Intern Med. 2003;139:810-816.
8. Chesney M, Ickovics J, Hecht F, et al. Adherence: a necessity for successful HIV combination therapy. AIDS. 1999;13(Suppl A):S271-S278.
9. Mannheimer S, Friedland G, Matts J, et al. The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus infected persons in clinical trials. Clin Infect Dis. 2002;34:1115-1121.
10. Chesney M, Morin M, Sherr L. Adherence to HIV combination therapy. Soc Sci Med. 2000;50:1599-1605.
11. Castro A. Adherence to antiretroviral therapy: merging the clinical and social course of AIDS. PLoS Med. 2005;2:e338.
12. Institute of Medicine (Committee on Health and Behavior: Research PaP). Health and Behavior: The Interplay of Biological, Behavioral, and Societal Influences: Board on Neuroscience and Behavioral Health. Washington, DC: National Academy Press; 2001.
13. Kleinman A, Eisenberg L, Good B. Clinical lessons from anthropologic and cross-cultural research. Ann Intern Med. 1978;88:251-258.
14. National Institutes of Health. Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents. Washington, DC: US Department of Health and Human Services; 2006.
15. Fisher J, Cornman D, Osborne C, et al. Clinician-initiated HIV-risk reduction intervention for HIV+ persons: formative research, acceptability, and fidelity of the Options Project. J Acquir Immune Defic Syndr. 2004;37(Suppl 2):S78-S87.
16. Altice F, Mostashari F, Friedland G. Trust and the acceptance of and adherence to antiretroviral therapy. J Acquir Immune Defic Syndr. 2001;28:47-58.
17. Haynes R, Taylor D, Sackett D. Compliance in Health Care. Baltimore, MD: Johns Hopkins University Press; 1979.
18. Sackett D, Snow J. The Magnitude of Compliance and Noncompliance. Baltimore, MD: Johns Hopkins University Press; 1979.
19. Roter D, Hall J, Merisca R, et al. Effectiveness of interventions to improve patient compliance - a meta analysis. Med Care. 1998;36:1138-1161.
20. Kassirer J. On the Take. New York: Oxford University Press; 2004.
21. Ickovics J, Meisler A. Adherence in AIDS clinical trials: a framework for clinical research and clinical care. J Clin Epidemiol. 1997;50:385-391.
22. Altice F, Friedland G. The era of adherence to HIV therapy. Ann Intern Med. 1998;129:503-505.
23. Paterson D, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21-30.
24. Fisher J, Fisher W, Cornman D, et al. Clinician-delivered intervention during routine clinical care reduces unprotected sexual behavior among HIV-infected patients. J Acquir Immune Defic Syndr. 2006;41:44-52.
25. Wedding D, Stuber ML. Behavior and Medicine. Seattle, WA: Hogrefe and Huber; 2006.
26. Green A, Betancourt J, Carrillo J. Integrating social factors into cross-cultural medical education. Acad Med. 2002;77:193-197.
27. Montgomery K. How Doctors Think: Clinical Judgment and the Practice of Medicine New York: Oxford University Press; 2006.
28. Henry K. The case for more cautious, patient-focused antiretroviral therapy. Ann Intern Med. 2000;132:306-311.
29. Bangsberg D, Moss A, Deeks S. Paradoxes of adherence and drug resistance to HIVantiretroviral therapy. J Antimicrob Chemother. 2004;53:696-699.
30. Harrigan P, Hogg R, Dong W, et al. Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy. J Infect Dis. 2005;191:339-347.